Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.7K Sell
131
-14
-10% -$1.62K 0.01% 99
2025
Q4
$15.3K Buy
145
+1
+0.7% +$94 0.01% 98
2025
Q3
$12.1K Buy
144
+1
+0.7% +$82 0.01% 102
2025
Q2
$11.3K Sell
143
-70
-33% -$5.56K 0.01% 104
2025
Q1
$19.1K Sell
213
-116
-35% -$10.8K 0.01% 89
2024
Q4
$32.7K Buy
329
+3
+0.9% +$309 0.02% 74
2024
Q3
$37.1K Buy
326
+2
+0.6% +$238 0.02% 75
2024
Q2
$40.2K Buy
324
+1
+0.3% +$129 0.02% 63
2024
Q1
$42.2K Buy
323
+3
+0.9% +$370 0.02% 64
2023
Q4
$34.9K Buy
320
+2
+0.6% +$208 0.02% 67
2023
Q3
$32.8K Buy
318
+2
+0.6% +$216 0.02% 68
2023
Q2
$36.5K Buy
316
+2
+0.6% +$227 0.02% 65
2023
Q1
$33.4K Buy
314
+2
+0.6% +$216 0.03% 68
2022
Q4
$34.6K Buy
312
+2
+0.6% +$204 0.03% 62
2022
Q3
$27K Sell
310
-22
-7% -$1.96K 0.02% 72
2022
Q2
$30K Buy
332
+2
+0.6% +$177 0.02% 70
2022
Q1
$27K Buy
330
+2
+0.6% +$158 0.02% 81
2021
Q4
$25K Buy
328
+176
+116% +$14K 0.02% 90
2021
Q3
$11K Sell
152
-194
-56% -$14.8K 0.01% 112
2021
Q2
$27K Sell
346
-13
-4% -$967 0.02% 84
2021
Q1
$26K Buy
359
+3
+0.8% +$221 0.02% 85
2020
Q4
$28K Buy
+356
New +$27.2K 0.02% 76

Other funds holding MRK

Financial Avengers's MRK Position: Q1 2026 in Review

Financial Avengers reduced its Merck (MRK) stake by 9.7% in Q1 2026, selling an estimated $1.62K and leaving 131 shares worth $15.7K. The position accounts for 0.01% of the portfolio, ranked #99.

Financial Avengers first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. The position peaked at $42.2K in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Financial Avengers held 131 shares of Merck worth $15.7K as of Q1 2026.
  • Financial Avengers sold 14 Merck shares in Q1 2026, an estimated $1.62K.
  • Merck made up 0.01% of Financial Avengers's portfolio in Q1 2026, its #99 holding.
  • Financial Avengers first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • Financial Avengers's Merck position peaked at $42.2K in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Financial Avengers's 13F filing for Q1 2026, filed 19 May 2026.